Kayvon Ghayoumi

Kayvon Ghayoumi handles appeals and complex civil litigation, focusing on intellectual property matters. 

He has extensive experience representing clients in high-stakes patent appeals in the U.S. Court of Appeals for the Federal Circuit.  Mr. Ghayoumi is also experienced in district court.  He has developed case strategy, drafted pleadings, managed discovery, deposed fact and expert witnesses, and drafted briefs in support of, or in opposition to, various motions.

Prior to joining MoloLamken, Mr. Ghayoumi served as a law clerk to the Honorable Richard G. Taranto of the United States Court of Appeals for the Federal Circuit. He also worked as an associate at Finnegan, Henderson, Farabow, Garrett & Dunner. 

Representative Matters

Appeals before the U.S. Court of Appeals for the Federal Circuit

• Agricultural sciences company in a Federal Circuit appeal defending the grant of a preliminary injunction concerning crop-protection products
• Pharmaceutical company and university in a Federal Circuit appeal defending a +$30 million jury verdict of patent infringement
• Pharmaceutical company in a Federal Circuit appeal defending the denial of a preliminary injunction concerning biologic drugs
• Telecommunications company in a Federal Circuit appeal challenging a +$150 million jury verdict of patent infringement
• Telecommunications company in a Federal Circuit appeal defending a district court’s denial of an antisuit injunction
• Memory-module developer in a Federal Circuit appeal defending a +$300 million jury verdict of patent infringement
• Memory-module developer in a series of Federal Circuit appeals challenging the Patent Trial and Appeal Board’s unpatentability rulings
• Advertising company in a Federal Circuit appeal challenging a district court’s ruling of patent-ineligibility
• Veterans in pro bono appeals before the Court of Appeals for Veterans Claims and the Federal Circuit

Other Appeals

• Trustee in its petition for a writ of certiorari in the Supreme Court regarding the scope of the federal securities laws
• Federal law-enforcement officer in his petition for a writ of certiorari in the Supreme Court regarding the scope of Bivens v. Six Unknown Named Agents of Federal Bureau of Narcotics
• Merchant in an appeal before the Fifth Circuit regarding the Federal Trade Commission’s burden in seeking monetary relief under § 19 of the Federal Trade Commission Act

District Court Litigation

• Proposed class of direct Apple Watch purchasers in an antitrust lawsuit against Apple Inc. in the District of New Jersey
• Biotech venture fund in a lawsuit alleging breach of fiduciary duty and misappropriation of intellectual property in the context of a $2 billion pharmaceutical merger
• Producer of dental appliance material in patent litigation against dental appliance maker in the District of Delaware
• Pharmaceutical companies in patent infringement suit brought under the Hatch-Waxman Act concerning generic versions of products used to treat schizophrenia and depression
• Pharmaceutical company in patent litigation in the District of New Jersey regarding a branded iron infusion therapy

Publications

• Trends in Attorney Fees and Sanctions Decisions in 2020 Q4, Westlaw Today (Apr. 15, 2021)

News & Appearances

• Regeneron Fails to Block Amgen's Eylea Biosimilar During Appeal, Bloomberg Law (Oct. 22, 2024)

• MDL court appoints direct Apple Watch purchaser and indirect iPhone purchaser interim class counsel, Wolters Kluwer (Oct. 21, 2024)

• Biotech Investor Sues In Chancery Over Alleged IP Diversions, Law360 (Aug. 26, 2024)

• Allergan Scoffs At Sandoz Bid To Undo $39M Patent Loss, Law360 (Mar. 29, 2024)

• AT&T, Nokia Turn To 1884 Precedent To Fight $181M Trial Loss, Law360 (Feb. 13, 2024)

• Justices Urged To Weigh If Syndicated Loans Are Securities, Law360 (Dec. 19, 2023)